Literature DB >> 26106166

Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease.

Jose A Santiago1, Judith A Potashkin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26106166      PMCID： PMC4507244          DOI： 10.1073/pnas.1508415112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  A network approach to clinical intervention in neurodegenerative diseases.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Trends Mol Med       Date:  2014-10-30       Impact factor: 11.951

3.  Metaanalysis of flawed expression profiling data leading to erroneous Parkinson's biomarker identification.

Authors:  Lilah Toker; Paul Pavlidis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

4.  Specific splice variants are associated with Parkinson's disease.

Authors:  Jose A Santiago; Clemens R Scherzer; Judith A Potashkin
Journal:  Mov Disord       Date:  2013-09-20       Impact factor: 10.338

5.  Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Authors:  Judith A Potashkin; Jose A Santiago; Bernard M Ravina; Arthur Watts; Alexey A Leontovich
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.